Post-irradiation cutaneous angiosarcoma
Open Access
- 16 October 2008
- journal article
- Published by Springer Science and Business Media LLC in Cases Journal
- Vol. 1 (1), 241-3
- https://doi.org/10.1186/1757-1626-1-241
Abstract
Angiosarcoma is a rare and highly malignant tumor with potential to recur despite treatment, and carries a poor prognosis. Previous radiation therapy and lymphedema are some of the known risk factors. We present a case of cutaneous angiosarcoma which occurred at lumpectomy site in a patient with a history of breast cancer and radiation to the breast. The tumor kept on recurring repetitively despite continual treatments, and the patient finally succumbed to the disease roughly four years after initial diagnosis.Keywords
This publication has 8 references indexed in Scilit:
- Retrospective review of treatment for angiosarcoma at Fox Chase Cancer Center over the past 15 yearsJournal of Clinical Oncology, 2007
- Weekly paclitaxel in metastatic angiosarcoma. A FNCLCC French Sarcoma Group (GSF-GETO) phase II trialJournal of Clinical Oncology, 2007
- Paclitaxel in patients (pts) with advanced angiosarcomasJournal of Clinical Oncology, 2007
- Treatment and Outcome of 82 Patients with AngiosarcomaAnnals of Surgical Oncology, 2007
- Angiosarcomas: Natural history and prognostic factors from 161 cases in three French institutionsJournal of Clinical Oncology, 2005
- Malignant vascular tumors in young patientsCancer, 1998
- Angiosarcoma: A report of 67 patients and a review of the literatureCancer, 1996
- Postirradiation sarcomas. A single-institution study and review of the literatureCancer, 1994